Kaylee M Armendariz, APRN-CNP | |
2878 Powell St, Springdale, AR 72764-7333 | |
(479) 872-3045 | |
(479) 419-5947 |
Full Name | Kaylee M Armendariz |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 3 Years |
Location | 2878 Powell St, Springdale, Arkansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033788195 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 216436 (Arkansas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St. Francis House Nwa, Inc. | 0042262495 | 38 |
News Archive
Bacteria that manufacture hydroxyapatite (HA) could be used to make stronger, more durable bone implants. Professor Lynne Macaskie from the University of Birmingham this week (7-10 September) presented work to the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh.
The National Action Alliance for Suicide Prevention, a public-private partnership created in September to address the preventable public health tragedy of suicide, announced today the creation of its first three task forces.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Habits are behaviors wired so deeply in our brains that we perform them automatically. This allows you to follow the same route to work every day without thinking about it, liberating your brain to ponder other things, such as what to make for dinner.
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
› Verified 8 days ago
Entity Name | St. Francis House Nwa, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417197245 PECOS PAC ID: 0042262495 Enrollment ID: O20090526000134 |
News Archive
Bacteria that manufacture hydroxyapatite (HA) could be used to make stronger, more durable bone implants. Professor Lynne Macaskie from the University of Birmingham this week (7-10 September) presented work to the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh.
The National Action Alliance for Suicide Prevention, a public-private partnership created in September to address the preventable public health tragedy of suicide, announced today the creation of its first three task forces.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Habits are behaviors wired so deeply in our brains that we perform them automatically. This allows you to follow the same route to work every day without thinking about it, liberating your brain to ponder other things, such as what to make for dinner.
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Kaylee M Armendariz, APRN-CNP 614 E Emma Ave Ste 300, Springdale, AR 72764-4469 Ph: (479) 751-7417 | Kaylee M Armendariz, APRN-CNP 2878 Powell St, Springdale, AR 72764-7333 Ph: (479) 872-3045 |
News Archive
Bacteria that manufacture hydroxyapatite (HA) could be used to make stronger, more durable bone implants. Professor Lynne Macaskie from the University of Birmingham this week (7-10 September) presented work to the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh.
The National Action Alliance for Suicide Prevention, a public-private partnership created in September to address the preventable public health tragedy of suicide, announced today the creation of its first three task forces.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Habits are behaviors wired so deeply in our brains that we perform them automatically. This allows you to follow the same route to work every day without thinking about it, liberating your brain to ponder other things, such as what to make for dinner.
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
› Verified 8 days ago
Katherine A Darling, DNP, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2400 S 48th St, Springdale, AR 72762 Phone: 479-750-2020 Fax: 479-750-4843 | |
Scott Grigg, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4301 Greathouse Springs Rd, Springdale, AR 72762 Phone: 479-684-3132 Fax: 479-684-3098 | |
Andrew Long, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 609 W Maple Ave, Springdale, AR 72764 Phone: 479-751-5711 | |
James Robert Feher, MSN, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4077 Elm Springs Rd Ste 105, Springdale, AR 72762 Phone: 479-927-2100 | |
Kelsey Breanne Smith, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 210 S Thompson St Ste 4a, Springdale, AR 72764 Phone: 479-445-9900 | |
Stephanie Burks, FNP-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 210 S Thompson St Ste 4a, Springdale, AR 72764 Phone: 479-445-9900 |